This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A recent study finds that administering IgA antibodies via nasal spray can fend off multiple omicron variants within the respiratory tract.
Elevated body temperature activates the key antiviral protein interferons effective in combating infections like COVID-19
